WO2008055626A8 - Protein-enthaltender stoff mit erhöhter temperaturstabilität - Google Patents

Protein-enthaltender stoff mit erhöhter temperaturstabilität

Info

Publication number
WO2008055626A8
WO2008055626A8 PCT/EP2007/009523 EP2007009523W WO2008055626A8 WO 2008055626 A8 WO2008055626 A8 WO 2008055626A8 EP 2007009523 W EP2007009523 W EP 2007009523W WO 2008055626 A8 WO2008055626 A8 WO 2008055626A8
Authority
WO
WIPO (PCT)
Prior art keywords
thermal stability
protein
increased thermal
containing substance
substance
Prior art date
Application number
PCT/EP2007/009523
Other languages
English (en)
French (fr)
Other versions
WO2008055626A1 (de
Inventor
Bruno Winter
Stephen Cole
Original Assignee
Ab Enzymes Gmbh
Bruno Winter
Stephen Cole
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ab Enzymes Gmbh, Bruno Winter, Stephen Cole filed Critical Ab Enzymes Gmbh
Priority to MX2009004992A priority Critical patent/MX2009004992A/es
Priority to CA002667976A priority patent/CA2667976A1/en
Priority to EP07819548A priority patent/EP2120893A1/de
Priority to US12/312,357 priority patent/US20100004170A1/en
Priority to BRPI0718692-4A priority patent/BRPI0718692A2/pt
Priority to AU2007316929A priority patent/AU2007316929A1/en
Priority to CN2007800417732A priority patent/CN101534801B/zh
Publication of WO2008055626A1 publication Critical patent/WO2008055626A1/de
Publication of WO2008055626A8 publication Critical patent/WO2008055626A8/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5089—Processes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/10—Feeding-stuffs specially adapted for particular animals for ruminants
    • A23K50/15—Feeding-stuffs specially adapted for particular animals for ruminants containing substances which are metabolically converted to proteins, e.g. ammonium salts or urea
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/30—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K40/00—Shaping or working-up of animal feeding-stuffs
    • A23K40/30—Shaping or working-up of animal feeding-stuffs by encapsulating; by coating
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L11/00—Pulses, i.e. fruits of leguminous plants, for production of food; Products from legumes; Preparation or treatment thereof
    • A23L11/05—Mashed or comminuted pulses or legumes; Products made therefrom
    • A23L11/07—Soya beans, e.g. oil-extracted soya bean flakes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/06—Enzymes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
    • A23L29/35—Degradation products of starch, e.g. hydrolysates, dextrins; Enzymatically modified starches
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P20/00—Coating of foodstuffs; Coatings therefor; Making laminated, multi-layered, stuffed or hollow foodstuffs
    • A23P20/10—Coating with edible coatings, e.g. with oils or fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5063—Compounds of unknown constitution, e.g. material from plants or animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Botany (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Animal Husbandry (AREA)
  • Organic Chemistry (AREA)
  • Physiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Agronomy & Crop Science (AREA)
  • Birds (AREA)
  • Fodder In General (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Die Erfindung betrifft einen Stoff mit erhöhter Temperaturstabilität, umfassend einen Kern und eine Coatingschicht, dadurch gekennzeichnet, dass der Kern mindestens ein biologisch aktives Protein umfasst, und dass die Coatingschicht ein mikronisiertes Leguminosenprodukt umfasst, ein Verfahren zur Herstellung dieses Stoffs sowie die Verwendung eines mikronisierten Leguminosenprodukts zur Erhöhung der Temperaturstabilität von biologisch aktiven Proteinen in Verfahren zur Herstellung eines granulierten Produkts, sowie in Verfahren zur Herstellung von Tierfutter, Lebensmitteln und Arzneimitteln.
PCT/EP2007/009523 2006-11-10 2007-11-02 Protein-enthaltender stoff mit erhöhter temperaturstabilität WO2008055626A1 (de)

Priority Applications (7)

Application Number Priority Date Filing Date Title
MX2009004992A MX2009004992A (es) 2006-11-10 2007-11-02 Sustancia que contiene proteinas con estabilidad termica incrementada.
CA002667976A CA2667976A1 (en) 2006-11-10 2007-11-02 Protein-containing agent with increased thermal stability
EP07819548A EP2120893A1 (de) 2006-11-10 2007-11-02 Protein-enthaltender stoff mit erhöhter temperaturstabilität
US12/312,357 US20100004170A1 (en) 2006-11-10 2007-11-02 Protein-containing substance with increased thermal stability
BRPI0718692-4A BRPI0718692A2 (pt) 2006-11-10 2007-11-02 Agente que contém proteína com elevada estabilidade térmica.
AU2007316929A AU2007316929A1 (en) 2006-11-10 2007-11-02 Protein-containing substance with increased thermal stability
CN2007800417732A CN101534801B (zh) 2006-11-10 2007-11-02 热稳定性增加的含蛋白物质

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102006053071.3 2006-11-10
DE102006053071A DE102006053071A1 (de) 2006-11-10 2006-11-10 Protein-enthaltender Stoff mit erhöhter Temperaturstabilität

Publications (2)

Publication Number Publication Date
WO2008055626A1 WO2008055626A1 (de) 2008-05-15
WO2008055626A8 true WO2008055626A8 (de) 2008-07-31

Family

ID=39251358

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2007/009523 WO2008055626A1 (de) 2006-11-10 2007-11-02 Protein-enthaltender stoff mit erhöhter temperaturstabilität

Country Status (11)

Country Link
US (1) US20100004170A1 (de)
EP (1) EP2120893A1 (de)
KR (1) KR20090079963A (de)
CN (1) CN101534801B (de)
AU (1) AU2007316929A1 (de)
BR (1) BRPI0718692A2 (de)
CA (1) CA2667976A1 (de)
DE (1) DE102006053071A1 (de)
MX (1) MX2009004992A (de)
WO (1) WO2008055626A1 (de)
ZA (1) ZA200903059B (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8030002B2 (en) 2000-11-16 2011-10-04 Curemark Llc Methods for diagnosing pervasive development disorders, dysautonomia and other neurological conditions
US20080058282A1 (en) 2005-08-30 2008-03-06 Fallon Joan M Use of lactulose in the treatment of autism
US8658163B2 (en) 2008-03-13 2014-02-25 Curemark Llc Compositions and use thereof for treating symptoms of preeclampsia
US8084025B2 (en) 2008-04-18 2011-12-27 Curemark Llc Method for the treatment of the symptoms of drug and alcohol addiction
US9320780B2 (en) 2008-06-26 2016-04-26 Curemark Llc Methods and compositions for the treatment of symptoms of Williams Syndrome
US11016104B2 (en) 2008-07-01 2021-05-25 Curemark, Llc Methods and compositions for the treatment of symptoms of neurological and mental health disorders
US10776453B2 (en) 2008-08-04 2020-09-15 Galenagen, Llc Systems and methods employing remote data gathering and monitoring for diagnosing, staging, and treatment of Parkinsons disease, movement and neurological disorders, and chronic pain
US20100092447A1 (en) 2008-10-03 2010-04-15 Fallon Joan M Methods and compositions for the treatment of symptoms of prion diseases
CA2747703C (en) 2009-01-06 2021-06-15 Curemark Llc Compositions and methods for the treatment or the prevention of infections by e. coli
EP2373791B1 (de) 2009-01-06 2016-03-30 Curelon LLC Zusammensetzungen enhaltend protease, amylase and lipase zur verwendung in der behandlung von staphylococcus aureus-infektionen
US9056050B2 (en) 2009-04-13 2015-06-16 Curemark Llc Enzyme delivery systems and methods of preparation and use
WO2011050135A1 (en) 2009-10-21 2011-04-28 Curemark Llc Methods and compositions for the prevention and treatment of influenza
US8980252B2 (en) 2011-04-21 2015-03-17 Curemark Llc Methods of treatment of schizophrenia
WO2013019789A1 (en) 2011-08-01 2013-02-07 Cfph, Llc Amusement devices and games involving multiple operators, multiple players, and/or multiple jurisdictions
US20150037491A1 (en) * 2012-02-07 2015-02-05 Danisco Us Inc. Phytic Acid as a Stabilizer for Phytase
US10350278B2 (en) 2012-05-30 2019-07-16 Curemark, Llc Methods of treating Celiac disease
DE102012217347A1 (de) 2012-09-26 2014-03-27 BSH Bosch und Siemens Hausgeräte GmbH Eingabevorrichtung für Elektrogerät
US9948354B2 (en) 2015-04-28 2018-04-17 At&T Intellectual Property I, L.P. Magnetic coupling device with reflective plate and methods for use therewith
WO2019232119A1 (en) * 2018-06-01 2019-12-05 Danisco Us Inc. High-payload, non-porous, enzyme-containing coated granules
CN111543620A (zh) * 2020-06-05 2020-08-18 山东肥城精制盐厂有限公司 一种热稳定的碱性蛋白食用盐
SE2050826A1 (en) * 2020-07-02 2022-01-03 Capitainer Ab Functionalized blood sampling device and method for peth measurement
US11541009B2 (en) 2020-09-10 2023-01-03 Curemark, Llc Methods of prophylaxis of coronavirus infection and treatment of coronaviruses

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1590432A (en) * 1976-07-07 1981-06-03 Novo Industri As Process for the production of an enzyme granulate and the enzyme granuate thus produced
US4777058A (en) * 1985-02-11 1988-10-11 Star-Kist Foods, Inc. Composite animal food
JPH0622455B2 (ja) * 1986-03-17 1994-03-30 味の素株式会社 油脂被覆された５′−リボヌクレオチド類
DE4119281A1 (de) * 1991-06-12 1992-12-17 Basf Ag Verfahren zur herstellung von enzymzubereitungen
US5387422A (en) * 1993-03-11 1995-02-07 Triarco Industries, Inc. Proteolytic fungal enzyme food supplement composition
KR950702625A (ko) * 1993-05-18 1995-07-29 한스 발터 라벤 비살포성 효소의 제조방법(process for dust-free enzyme manufacture)
CN1159208A (zh) * 1995-07-28 1997-09-10 吉斯特·布罗卡迪斯股份有限公司 盐稳定化酶制剂
DE69732775T2 (de) * 1996-04-12 2006-01-26 Novozymes A/S Enzymhaltige granulatkörner sowie verfahren zu deren herstellung
ATE341619T1 (de) * 1997-12-20 2006-10-15 Genencor Int In einem wirbelschichtbett hergestelltes matrixgranulat
ES2212568T3 (es) * 1998-06-30 2004-07-16 Novozymes A/S Nuevo granulo mejorado que contiene una enzima.
US6610519B1 (en) * 1998-10-02 2003-08-26 Novozymes A/S Solid phytase composition stabilized with lactic acid provided by corn steep liquor
ATE312171T1 (de) * 1999-10-01 2005-12-15 Novozymes As Sprühgetrocknetes enzymprodukt
ES2597503T3 (es) * 2001-10-31 2017-01-19 Huvepharma Eood Alimento para animales que contiene fitasa y método
CN1656205A (zh) * 2002-07-01 2005-08-17 诺和酶股份有限公司 颗粒的稳定
CA2435053C (en) * 2003-07-11 2011-08-16 Nancy Ames Processed barley food products

Also Published As

Publication number Publication date
AU2007316929A1 (en) 2008-05-15
DE102006053071A1 (de) 2008-05-15
BRPI0718692A2 (pt) 2013-12-31
CA2667976A1 (en) 2008-05-15
ZA200903059B (en) 2010-04-28
MX2009004992A (es) 2009-05-20
CN101534801A (zh) 2009-09-16
WO2008055626A1 (de) 2008-05-15
CN101534801B (zh) 2012-05-02
EP2120893A1 (de) 2009-11-25
US20100004170A1 (en) 2010-01-07
KR20090079963A (ko) 2009-07-22

Similar Documents

Publication Publication Date Title
WO2008055626A8 (de) Protein-enthaltender stoff mit erhöhter temperaturstabilität
EG26976A (en) Amide derivatives, process for production of the same, and method for application thereof as insecticide
WO2007082693A3 (en) Improved enzyme formulations for animal feed
IL174919A0 (en) Diamine derivatives, process for the production thereof and plant disease control compositions containing the same
WO2008043076A3 (en) Use of low ph to modify the texture of structured plant protein products
MX2009003064A (es) Proceso para elaborar productos de proteina vegetal estructurada coloreados.
WO2006125620A3 (en) Cores and microcapsules suitable for parenteral administration as well as process for their manufacture
WO2004081193A3 (en) Method for producing ethanol using raw starch
WO2013070798A3 (en) Food protein ingredient and methods for producing
WO2008000050A3 (en) Method for making soluble arabinoxylans as co-product of fermentation of whole-grain cereals
WO2006119386A3 (en) Methods and systems for producing ethanol using raw starch and fractionation
WO2005059155A3 (de) Verfahren zur isolierung von methionin aus einem fermentationsüberstand
WO2008012343A3 (en) Macrolide synthesis process
WO2006053761A3 (en) Modified plant gums for preparations of active ingredients
WO2008130312A8 (en) A new process for the manufacturing of the compound 2-hydroxy-3-[5-(morpholin-4-ylmethyl)pyridin-2-yl]1h-indole-5-carbonitrile 701
CA2534593A1 (en) Process for preparing a food product using depolymerised pectin as stabiliser
EP2042184A4 (de) Physiologish aktives polypeptid, polymermizelle mit darin eingeschlossenem protein und verfahren zur herstellung der polymermizelle
EP1896650A4 (de) Verfahren zur herstellung von hochwertigen fasern aus weizenproteinen und aus weizenproteinfasern hergestellte produkte
LT1928255T (lt) Pieno produktų gamybos būdas, tuo būdu gauti produktai ir jų panaudojimas
EP1563841A4 (de) Heilmittel
PL377741A1 (pl) Pochodne diarylocykloalkilowe, sposób ich wytwarzania i ich zastosowanie jako środka leczniczego
ID22769A (id) Proses untuk membuat suplemen makanan ternak mengalir-bebas yang didasarkan pada garam metionina dan bahan butiran yang dapat diperoleh dari garam tersebut
EP1719523A4 (de) Mikropartikuläre proteinarzneistoff-retardzubereitung zur injektion und verfahren für deren herstellung
EP1859689A4 (de) Verfahren zur herstellung eines maisverarbeitungsprodukts
DE602005010963D1 (de) Verfahren zur herstellung eines essbares produkt mit geschmacks-mikrokapseln

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 200780041773.2

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07819548

Country of ref document: EP

Kind code of ref document: A1

DPE1 Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2007316929

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2667976

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 12009500859

Country of ref document: PH

WWE Wipo information: entry into national phase

Ref document number: MX/A/2009/004992

Country of ref document: MX

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 2007316929

Country of ref document: AU

Date of ref document: 20071102

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 1020097010993

Country of ref document: KR

WWE Wipo information: entry into national phase

Ref document number: 2007819548

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 12312357

Country of ref document: US

ENP Entry into the national phase

Ref document number: PI0718692

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20090511